Suppr超能文献

炎症性肠病患者的代谢功能障碍相关脂肪性肝病:一项初步研究。

Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Inflammatory Bowel Diseases: A Pilot Study.

作者信息

Abenavoli Ludovico, Spagnuolo Rocco, Scarlata Giuseppe Guido Maria, Gambardella Maria Luisa, Boccuto Luigi, Méndez-Sánchez Nahum, Luzza Francesco

机构信息

Department of Health Sciences, University "Magna Græcia", Viale Europa, 88100 Catanzaro, Italy.

Healthcare Genetics and Genomics Doctoral Program, School of Nursing, College of Behavioral, Social and Health Sciences, Clemson University, Clemson, SC 29634, USA.

出版信息

Life (Basel). 2024 Sep 25;14(10):1226. doi: 10.3390/life14101226.

Abstract

BACKGROUND

Inflammatory bowel disease (IBD) is characterized by persistent inflammation and is often associated with metabolic dysfunction-associated steatotic liver disease (MASLD). IBD patients are at risk of developing MASLD due to shared risk factors such as gut dysbiosis and systemic inflammation. The new MASLD nomenclature emphasizes the link between liver steatosis and cardiometabolic comorbidities. However, the prevalence of MASLD in IBD patients remains poorly explored. The main aim of this cross-sectional study is to assess the prevalence of ultrasound (US) and the clinical features of MASLD in patients with IBDs.

MATERIALS AND METHODS

We conducted a retrospective study enrolling 272 Italian IBD patients attending Renato Dulbecco Teaching Hospital in a period between 1 January 2021 and 31 December 2023. MASLD was diagnosed based on the presence of liver steatosis with cardiometabolic risk factors, using established guidelines. Demographic, clinical, and laboratory data were collected and analyzed. Statistical significance was determined at a -value < 0.05.

RESULTS

Of the 272 IBD patients, 6% had non-alcoholic fatty liver disease (NAFLD), while 18% had MASLD. Patients with IBD-MASLD were significantly older, had higher body mass index, waist circumference, and triglyceride levels, and were more likely to have type 2 diabetes mellitus and hypertension compared to those with IBD-NAFLD. IBD-MASLD patients also showed higher disease activity scores and required more frequent surgical interventions. Bivariate logistic regression revealed triglyceride levels as a significant predictor of MASLD in IBD patients.

CONCLUSIONS

MASLD is more prevalent in IBD patients, highlighting the importance of early detection of liver steatosis in this at-risk population. The association between MASLD and cardiometabolic risk factors underscores the need for a multidisciplinary approach to manage these patients effectively. Further studies in larger cohorts are necessary to confirm these findings and explore the pathophysiological mechanisms involved.

摘要

背景

炎症性肠病(IBD)的特征是持续炎症,且常与代谢功能障碍相关脂肪性肝病(MASLD)有关。由于肠道菌群失调和全身炎症等共同危险因素,IBD患者有发生MASLD的风险。新的MASLD命名法强调了肝脏脂肪变性与心脏代谢合并症之间的联系。然而,IBD患者中MASLD的患病率仍未得到充分研究。这项横断面研究的主要目的是评估IBD患者中超声(US)诊断MASLD的患病率及其临床特征。

材料与方法

我们进行了一项回顾性研究,纳入了2021年1月1日至2023年12月31日期间在雷纳托·杜尔贝科教学医院就诊的272例意大利IBD患者。根据既定指南,基于存在肝脏脂肪变性及心脏代谢危险因素来诊断MASLD。收集并分析了人口统计学、临床和实验室数据。以P值<0.05确定统计学显著性。

结果

在272例IBD患者中,6%患有非酒精性脂肪性肝病(NAFLD),而18%患有MASLD。与IBD-NAFLD患者相比,IBD-MASLD患者年龄显著更大,体重指数、腰围和甘油三酯水平更高,且更有可能患有2型糖尿病和高血压。IBD-MASLD患者还表现出更高的疾病活动评分,需要更频繁的手术干预。二元逻辑回归显示甘油三酯水平是IBD患者发生MASLD的显著预测因素。

结论

MASLD在IBD患者中更为普遍,凸显了在这一高危人群中早期检测肝脏脂肪变性的重要性。MASLD与心脏代谢危险因素之间的关联强调了采用多学科方法有效管理这些患者的必要性。有必要在更大的队列中进行进一步研究以证实这些发现并探索其中涉及的病理生理机制。

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验